Richard Hoppe

Publications

• STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE
  Advani, R. H., Hoppe, R. T., Maeda, L. S., Baer, D. M., Mason, J., & Horning, S. J. (2011). STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(5), 1374-1379.
• REVISITING LOW-DOSE TOTAL SKIN ELECTRON BEAM THERAPY IN MYCOSIS FUNGOIDES
  Harrison, C., Young, J., Navi, D., Riaz, N., Lingala, B., & Hoppe, R. (2011). REVISITING LOW-DOSE TOTAL SKIN ELECTRON BEAM THERAPY IN MYCOSIS FUNGOIDES. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(4), E651-E657.
• In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
  Brody, J. D., Ai, W. Z., Czerwinski, D. K., Torchia, J. A., Levy, M., & Levy, R. (2010). In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study. JOURNAL OF CLINICAL ONCOLOGY, 28(28), 4324-4332.
• TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors Kohrt, H. E., Turnbull, B. B., Heydari, K., Shizuru, J. A., Laport, G. G., & Lowsky, R. (2009). TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. BLOOD, 114(5), 1099-1109.
  
• Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells Mattoch, I. W., Fulton, R., Kim, Y., Hoppe, R., Warnke, R. A., & Sundram, U. N. (2009). Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(6), 810-819.
  
• Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma Characterization of Clinical Subset With Worse Outcome Woo, D. K., Jones, C. R., Vanoli-Storz, M. N., Kohler, S., Reddy, S., & Kim, Y. H. (2009). Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma Characterization of Clinical Subset With Worse Outcome. ARCHIVES OF DERMATOLOGY, 145(6), 667-674.
  
• Low Stage Follicular Lymphoma: Biologic and Clinical Characterization According to Nodal or Extranodal Primary Origin Weinberg, O. K., Ma, L., Seo, K., Beck, A. H., Pai, R. K., & Arber, D. A. (2009). Low Stage Follicular Lymphoma: Biologic and Clinical Characterization According to Nodal or Extranodal Primary Origin. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 33(4), 591-598.
  
• Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease Kohrt, H., Johannsen, A., Hoppe, R., Horning, S. J., Rosenberg, S. A., & Lee, P. P. (2009). Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease. ONCOLOGY RESEARCH, 18(5-6), 287-292.
  
• Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab Morales, A. V., Advani, R., Horwitz, S. M., Riaz, N., Reddy, S., & Kim, Y. H. (2008). Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 59(6), 953-957.
  
• Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease Lee, J., Viakhireva, N., Cesca, C., Lee, P., Kohler, S., & Kim, Y. H. (2008). Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 59(4), 706-712.
  
• Hodgkin disease/lymphoma. Hoppe, R. T., Advani, R. H., Ambinder, R. F., Bierman, P. J., Bloomfield, C. D., & Zelenetz, A. D. (2008). Hodgkin disease/lymphoma. Journal of the National Comprehensive Cancer Network , 6(6), 594-622.
  
• Tolerance and chimerism after renal and hematopoietic-cell transplantation. Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Millan, M. T., & Strober, S. (2008). Tolerance and chimerism after renal and hematopoietic-cell transplantation. New England journal of medicine, 358(4), 362-368.
  
• Hodgkin's lymphoma: The role of radiation in the modern combined strategies of treatment Hoppe, R. T. (2007). Hodgkin's lymphoma: The role of radiation in the modern combined strategies of treatment. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 21(5), 915-?.
  
• Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease Advani, R., Maeda, L., Lavori, P., Quon, A., Hoppe, R., & Horning, S. J. (2007). Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 25(25), 3902-3907.
  
• TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC) Kim, Y. H., Willemze, R., Pimpinelli, N., Whittaker, S., Olsens, E. A., & Hoppe, R. T. (2007). TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). BLOOD, 110(2), 479-484.
  
• Revised response criteria for malignant lymphoma Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., & Diehl, V. (2007). Revised response criteria for malignant lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 25(5), 579-586.
  
• Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease Heidenreich, P. A., Schnittger, I., Strauss, H. W., Vagelos, R. H., Lee, B. K., & Hancock, S. L. (2007). Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 25(1), 43-49.
  
• Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome - Evidence from population-based and clinical cohorts Huang, K. P., Weinstock, M. A., Clarke, C. A., McMillan, A., Hoppe, R. T., & Kim, Y. H. (2007). Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome - Evidence from population-based and clinical cohorts. ARCHIVES OF DERMATOLOGY, 143(1), 45-50.
  
• Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography Tsai, E. Y., Taur, A., Espinosa, L., Quon, A., Johnson, D., & Kim, Y. H. (2006). Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography. ARCHIVES OF DERMATOLOGY, 142(5), 577-584.
  
• Protective conditioning for acute graft-versus-host disease Lowsky, R., Takahashi, T., Liu, Y. P., Dejbakhsh-Jones, S., GRUMET, F. C., & Strober, S. (2005). Protective conditioning for acute graft-versus-host disease. NEW ENGLAND JOURNAL OF MEDICINE, 353(13), 1321-1331.
  
• A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies Flores, M. G., Holm, B., Larson, M. J., Lau, M. K., Si, M. S., & Borie, D. C. (2005). A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies. JOURNAL OF SURGICAL RESEARCH, 124(2), 280-288.
  
• Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study Sundram, U., Kim, Y., Mraz-Gernhard, S., Hoppe, R., Natkunam, Y., & Kohler, S. (2005). Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study. JOURNAL OF CUTANEOUS PATHOLOGY, 32(3), 227-234.
  
• Short tandem repeat analysis to monitor chimerism in Macaca fascicularis Lau, M., Vayntrub, T., GRUMET, F. C., Lowsky, R., Strober, S., & Borie, D. (2004). Short tandem repeat analysis to monitor chimerism in Macaca fascicularis. AMERICAN JOURNAL OF TRANSPLANTATION, 4(9), 1543-1548.
  
• Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients Beynet, D. P., Wee, S. A., Horwitz, S. S., Kohler, S., Horning, S., & Kim, Y. H. (2004). Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients. ARCHIVES OF DERMATOLOGY, 140(9), 1140-1146.
  
• Extranodal nonorbital indolent lymphomas of the head and neck: Relationship between tumor control and radiotherapy MacDermed, D., Thurber, L., George, T. I., Hoppe, R. T., & Le, Q. T. (2004). Extranodal nonorbital indolent lymphomas of the head and neck: Relationship between tumor control and radiotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 59(3), 788-795.
  
• CD30(+) cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma Liu, H. L., Hoppe, R. T., Kohler, S., Harvell, J. D., Reddy, S., & Kim, Y. H. (2003). CD30(+) cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 49(6), 1049-1058.
  
• Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression Kim, Y. H., Liu, H. L., Mraz-Gernhard, S., Varghese, A., & Hoppe, R. T. (2003). Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression. ARCHIVES OF DERMATOLOGY, 139(7), 857-866.
  
• Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial Ekstrand, B. C., Lucas, J. B., Horwitz, S. M., Fan, Z., Breslin, S., & Horning, S. J. (2003). Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. BLOOD, 101(11), 4285-4289.
  
• Gene expression profiles of cutaneous B cell lymphoma Storz, M. N., van de Rijn, M., Kim, Y. H., Mraz-Gernhard, S., Hoppe, R. T., & Kohler, S. (2003). Gene expression profiles of cutaneous B cell lymphoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 120(5), 865-870.
  
• Topical nitrogen mustard in the management of mycosis fungoides - Update of the Stanford experience Kim, Y. H., Martinez, G., Varghese, A., & Hoppe, R. T. (2003). Topical nitrogen mustard in the management of mycosis fungoides - Update of the Stanford experience. ARCHIVES OF DERMATOLOGY, 139(2), 165-173.
  
• Mycosis fungoides: radiation therapy. Hoppe, R. T. (2003). Mycosis fungoides: radiation therapy. Dermatologic therapy, 16(4), 347-354.
  
• Hodgkin's disease: A model for interdisciplinary cancer management: 2002 Janeway Lecture Hoppe, R. T. (2002). Hodgkin's disease: A model for interdisciplinary cancer management: 2002 Janeway Lecture. CANCER JOURNAL, 8(6), 425-431.
  
• Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients Chin, C., Hunt, S., Robbins, R., Hoppe, R., Reitz, B., & Bernstein, D. (2002). Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 21(6), 667-673.
  
• Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation Millan, T. Lt., Shizuru, J. A., Hoffmann, P., Dejbakhsh-Jones, S., Scandling, J. D., & Strober, S. (2002). Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. TRANSPLANTATION, 73(9), 1386-1391.
  
• Primary radiotherapy for localized orbital malt lymphoma Le, Q. T., Eulau, S. M., George, T. I., Hildebrand, R., Warnke, R. A., & Hoppe, R. T. (2002). Primary radiotherapy for localized orbital malt lymphoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 52(3), 657-663.
  
• Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial Horning, S. J., Hoppe, R. T., Breslin, S., Bartlett, N. L., Brown, B. W., & Rosenberg, S. A. (2002). Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial. JOURNAL OF CLINICAL ONCOLOGY, 20(3), 630-637.
  
• NCCN: Non-Hodgkin's lymphoma. Zelenetz, A. D., & Hoppe, R. T. (2001). NCCN: Non-Hodgkin's lymphoma. Cancer control , 8(6), 102-113.
  
• Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course Mraz-Gernhard, S., Natkunam, Y., Hoppe, R. T., Leboit, P., Kohler, S., & Kim, Y. H. (2001). Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course. JOURNAL OF CLINICAL ONCOLOGY, 19(8), 2179-2188.
  
• Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides de Coninck, E. C., Kim, Y. H., Varghese, A., & Hoppe, R. T. (2001). Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides. JOURNAL OF CLINICAL ONCOLOGY, 19(3), 779-784.
  
• High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial Horning, S. J., Negrin, R. S., Hoppe, R. T., Rosenberg, S. A., Chao, N. J., & Blume, K. G. (2001). High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. BLOOD, 97(2), 404-409.
  
• High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience Cao, T. M., Horning, S. F., Negrin, R. S., Hu, W. W., Johnston, L. F., & Stockerl-Goldstein, K. (2001). High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 7(5), 294-301.
  
• Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University Murtha, A. D., Knox, S. J., Hoppe, R. T., Rupnow, B. A., & Hanson, J. (2001). Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 49(1), 3-15.
  
• Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group Pilot Study E1492 Horning, S. J., Wiliams, J., Bartlett, N. L., Bennett, J. M., Hoppe, R. T., & Cassileth, P. (2000). Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group Pilot Study E1492. JOURNAL OF CLINICAL ONCOLOGY, 18(5), 972-980.
  
• Management of breast cancer after Hodgkin's disease Wolden, S. L., Hancock, S. L., Carlson, R. W., Goffinet, D. R., Jeffrey, S. S., & Hoppe, R. T. (2000). Management of breast cancer after Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 18(4), 765-772.
  
• Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma Johnston, L. J., Stockerl-Goldstein, K. E., Hu, W. W., Negrin, R. S., Hoppe, R. T., & Horning, S. J. (2000). Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(5A), 555-562.
  
• What is the significance of nasal involvement in nasopharyngeal carcinoma? Lin, Z. X., Li, D. R., Chen, Z. J., Zheng, M. Z., Shi, Y. Y., & Hoppe, R. T. (1999). What is the significance of nasal involvement in nasopharyngeal carcinoma?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 45(4), 907-914.
  
• The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects. Donaldson, S. S., Hancock, S. L., & Hoppe, R. T. (1999). The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects. cancer journal from Scientific American, 5(6), 325-333.
  
• Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides Chui, C. T., Hoppe, R. T., Kohler, S., & Kim, Y. H. (1999). Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 41(2), 271-274.
  
• Mycosis fungoides and the Sezary syndrome Kim, Y. H., & Hoppe, R. T. (1999). Mycosis fungoides and the Sezary syndrome. SEMINARS IN ONCOLOGY, 26(3), 276-289.
  
• Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides Chinn, D. M., Chow, S., Kim, Y. H., & Hoppe, R. T. (1999). Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 43(5), 951-958.
  
• Results of the 1988-1989 patterns of care study process survey for Hodgkin's disease Smitt, M. C., Stouffer, N., Owen, J. B., Hoppe, R. T., & Hanks, G. E. (1999). Results of the 1988-1989 patterns of care study process survey for Hodgkin's disease. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 43(2), 335-339.
  
• Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides Kim, Y. H., Chow, S., Varghese, A., & Hoppe, R. T. (1999). Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. ARCHIVES OF DERMATOLOGY, 135(1), 26-32.
  
• Role of histology in providing prognostic information in mycosis fungoides SMOLLER, B. R., Detwiler, S. P., Kohler, S., Hoppe, R. T., & Kim, Y. H. (1998). Role of histology in providing prognostic information in mycosis fungoides. JOURNAL OF CUTANEOUS PATHOLOGY, 25(6), 311-315.
  
• Mycosis fungoides in young patients: Clinical characteristics and outcome Crowley, J. J., Nikko, A., Varghese, A., Hoppe, R. T., & Kim, Y. H. (1998). Mycosis fungoides in young patients: Clinical characteristics and outcome. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 38(5), 696-701.
  
• Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease. Hoppe, R. T. (1998). Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease. Annals of oncology , 9, S87-90.
  
• Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection Wolden, S. L., Tate, D. J., Hunt, S. A., Strober, S., & Hoppe, R. T. (1997). Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 39(5), 953-960.
  
• Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Long, G. D., Amylon, M. D., Stockerl-Goldstein, K. E., Negrin, R. S., Chao, N. J., & Blume, K. G. (1997). Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Biology of blood and marrow transplantation , 3(6), 324-330.
  
• Long-term depletion of naive T cells in patients treated for Hodgkin's disease Watanabe, N., DeRosa, S. C., Cmelak, A., Hoppe, R., Herzenberg, L. A., & Roederer, M. (1997). Long-term depletion of naive T cells in patients treated for Hodgkin's disease. BLOOD, 90(9), 3662-3672.
  
• Non-Hodgkin's lymphoma of the paranasal sinuses: Clinical and pathological features, and response to combined-modality therapy Hausdorff, J., Davis, E., Long, G., Hoppe, R., VANDERPAS, M., & Jacobs, C. (1997). Non-Hodgkin's lymphoma of the paranasal sinuses: Clinical and pathological features, and response to combined-modality therapy. CANCER JOURNAL, 3(5), 303-311.
  
• Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease: Subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation Horning, S. J., Hoppe, R. T., Mason, J., Brown, B. W., Hancock, S. L., & Rosenberg, S. A. (1997). Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease: Subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. JOURNAL OF CLINICAL ONCOLOGY, 15(5), 1736-1744.
  
• Detection of relapse in early-stage Hodgkin's disease: Role of routine follow-up studies TORREY, M. J., Poen, J. C., & Hoppe, R. T. (1997). Detection of relapse in early-stage Hodgkin's disease: Role of routine follow-up studies. JOURNAL OF CLINICAL ONCOLOGY, 15(3), 1123-1130.
  
• Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease Yuen, A. R., Rosenberg, S. A., Hoppe, R. T., HALPERN, J. D., & Horning, S. J. (1997). Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. BLOOD, 89(3), 814-822.
  
• High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices Horning, S. J., Chao, N. J., Negrin, R. S., Hoppe, R. T., Long, G. D., & Blume, K. G. (1997). High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices. BLOOD, 89(3), 801-813.
  
• Over 20 Years of Progress in Radiation Oncology: Hodgkin's Disease. Smitt, M. C., Buzydlowski, J., & Hoppe, R. T. (1997). Over 20 Years of Progress in Radiation Oncology: Hodgkin's Disease. Seminars in radiation oncology, 7(2), 127-134.
  
• Gastrointestinal cancer after treatment of Hodgkin's disease Birdwell, S. H., Hancock, S. L., Varghese, A., Cox, R. S., & Hoppe, R. T. (1997). Gastrointestinal cancer after treatment of Hodgkin's disease. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 37(1), 67-73.
  
• Hodgkin's disease: Complications of therapy and excess mortality Hoppe, R. T. (1997). Hodgkin's disease: Complications of therapy and excess mortality. ANNALS OF ONCOLOGY, 8, 115-118.
  
• Clinical stage IA (limited patch and plaque) mycosis fungoides - A long-term outcome analysis Kim, Y. H., Jensen, R. A., WATANABE, G. L., Varghese, A., & Hoppe, R. T. (1996). Clinical stage IA (limited patch and plaque) mycosis fungoides - A long-term outcome analysis. ARCHIVES OF DERMATOLOGY, 132(11), 1309-1313.
  
• High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival Poen, J. C., Hoppe, R. T., & Horning, S. J. (1996). High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 36(1), 3-12.
  
• Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma. Stockerl-Goldstein, K. E., Horning, S. J., Negrin, R. S., Chao, N. J., Hu, W. W., & Blume, K. G. (1996). Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma. Biology of blood and marrow transplantation , 2(2), 76-85.
  
• Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University MacManus, M. P., & Hoppe, R. T. (1996). Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. JOURNAL OF CLINICAL ONCOLOGY, 14(4), 1282-1290.
  
• Treatment of cutaneous T-Cell lymphoma with chimeric anti-CD4 monoclonal antibody Knox, S., Hoppe, R. T., Maloney, D., Gibbs, I., Fowler, S., & Levy, R. (1996). Treatment of cutaneous T-Cell lymphoma with chimeric anti-CD4 monoclonal antibody. BLOOD, 87(3), 893-899.
  
• Hodgkin's disease - The role of radiation therapy in advanced disease Hoppe, R. T. (1996). Hodgkin's disease - The role of radiation therapy in advanced disease. ANNALS OF ONCOLOGY, 7, 99-103.
  
• Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update Horning, S. J., Rosenberg, S. A., & Hoppe, R. T. (1996). Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update. ANNALS OF ONCOLOGY, 7, 105-108.
  
• Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. Hancock, S. L., & Hoppe, R. T. (1996). Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. Seminars in radiation oncology, 6(3), 225-242.
  
• PROGNOSTIC FACTORS IN ERYTHRODERMIC MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME Kim, Y. H., Bishop, K., Varghese, A., & Hoppe, R. T. (1995). PROGNOSTIC FACTORS IN ERYTHRODERMIC MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME. ARCHIVES OF DERMATOLOGY, 131(9), 1003-1008.
  
• MULTIPLE COURSES OF HIGH-DOSE TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MANAGEMENT OF MYCOSIS-FUNGOIDES Becker, M., Hoppe, R. T., & Knox, S. J. (1995). MULTIPLE COURSES OF HIGH-DOSE TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MANAGEMENT OF MYCOSIS-FUNGOIDES. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 32(5), 1445-1449.
  
• PELVIC RELAPSE FOLLOWING SUBTOTAL LYMPHOID IRRADIATION IN EARLY-STAGE HODGKINS-DISEASE - AN ANALYSIS OF RISK, MANAGEMENT, AND OUTCOME Tate, D. J., & Hoppe, R. T. (1995). PELVIC RELAPSE FOLLOWING SUBTOTAL LYMPHOID IRRADIATION IN EARLY-STAGE HODGKINS-DISEASE - AN ANALYSIS OF RISK, MANAGEMENT, AND OUTCOME. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 32(4), 1239-1244.
  
• BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT Bartlett, N. L., Rosenberg, S. A., Hoppe, R. T., Hancock, S. L., & Horning, S. J. (1995). BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT. JOURNAL OF CLINICAL ONCOLOGY, 13(5), 1080-1088.
  
• CD8-POSITIVE TUMOR-INFILTRATING LYMPHOCYTES INFLUENCE THE LONG-TERM SURVIVAL OF PATIENTS WITH MYCOSIS-FUNGOIDES Hoppe, R. T., Medeiros, L. J., Warnke, R. A., & Wood, G. S. (1995). CD8-POSITIVE TUMOR-INFILTRATING LYMPHOCYTES INFLUENCE THE LONG-TERM SURVIVAL OF PATIENTS WITH MYCOSIS-FUNGOIDES. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 32(3), 448-453.
  
• FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE PLUS AUTOGRAFTING IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA Horning, S. J., Negrin, R. S., Chao, N. J., Long, G. D., Hoppe, R. T., & Blume, K. G. (1994). FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE PLUS AUTOGRAFTING IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA. JOURNAL OF CLINICAL ONCOLOGY, 12(12), 2552-2558.
  
• TREATMENT OF EARLY-STAGE GASTRIC LYMPHOMA BenYosef, R., & Hoppe, R. T. (1994). TREATMENT OF EARLY-STAGE GASTRIC LYMPHOMA. JOURNAL OF SURGICAL ONCOLOGY, 57(2), 78-86.
  
• EFFECT OF TREATMENT FOR HODGKINS-DISEASE ON PULMONARY-FUNCTION - RESULTS OF A PROSPECTIVE-STUDY Horning, S. J., Adhikari, A., Rizk, N., Hoppe, R. T., & Olshen, R. A. (1994). EFFECT OF TREATMENT FOR HODGKINS-DISEASE ON PULMONARY-FUNCTION - RESULTS OF A PROSPECTIVE-STUDY. JOURNAL OF CLINICAL ONCOLOGY, 12(2), 297-305.
  
• EFFECT OF FILGRASTIM (G-CSF) IN HODGKINS-DISEASE PATIENTS TREATED WITH RADIATION Knox, S. J., Fowler, S., Marquez, C., & Hoppe, R. T. (1994). EFFECT OF FILGRASTIM (G-CSF) IN HODGKINS-DISEASE PATIENTS TREATED WITH RADIATION. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 28(2), 445-450.
  
• FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE Hancock, S. L., TUCKER, M. A., & Hoppe, R. T. (1993). FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 270(16), 1949-1955.
  
• CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS Hancock, S. L., Donaldson, S. S., & Hoppe, R. T. (1993). CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS. JOURNAL OF CLINICAL ONCOLOGY, 11(7), 1208-1215.
  
• MR-IMAGING TO DETECT CHEST-WALL AND PLEURAL INVOLVEMENT IN PATIENTS WITH LYMPHOMA - EFFECT ON RADIATION-THERAPY PLANNING CARLSEN, S. E., Bergin, C. J., & Hoppe, R. T. (1993). MR-IMAGING TO DETECT CHEST-WALL AND PLEURAL INVOLVEMENT IN PATIENTS WITH LYMPHOMA - EFFECT ON RADIATION-THERAPY PLANNING. AMERICAN JOURNAL OF ROENTGENOLOGY, 160(6), 1191-1195.
  
• HODGKINS-DISEASE WITH BULKY MEDIASTINAL INVOLVEMENT - EFFECTIVE MANAGEMENT WITH COMBINED MODALITY THERAPY BEHAR, R. A., Horning, S. J., & Hoppe, R. T. (1993). HODGKINS-DISEASE WITH BULKY MEDIASTINAL INVOLVEMENT - EFFECTIVE MANAGEMENT WITH COMBINED MODALITY THERAPY. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 25(5), 771-776.
  
• MYCOSIS-FUNGOIDES - CLINICAL AND HISTOLOGIC FEATURES, STAGING, EVALUATION, AND APPROACH TO TREATMENT Abel, E. A., Wood, G. S., & Hoppe, R. T. (1993). MYCOSIS-FUNGOIDES - CLINICAL AND HISTOLOGIC FEATURES, STAGING, EVALUATION, AND APPROACH TO TREATMENT. CA-A CANCER JOURNAL FOR CLINICIANS, 43(2), 93-115.
  
• BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE Hancock, S. L., TUCKER, M. A., & Hoppe, R. T. (1993). BREAST-CANCER AFTER TREATMENT OF HODGKINS-DISEASE. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 85(1), 25-31.
  
• SECONDARY LEUKEMIA AND MYELODYSPLASTIC SYNDROME AFTER TREATMENT FOR HODGKINS-DISEASE Hoppe, R. T. (1992). SECONDARY LEUKEMIA AND MYELODYSPLASTIC SYNDROME AFTER TREATMENT FOR HODGKINS-DISEASE. LEUKEMIA, 6, 155-157.
  
• THE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE, ALKERAN AND VINBLASTINE (PAVE) AND RADIOTHERAPY FOR LOCALLY EXTENSIVE AND ADVANCED STAGE HODGKINS-DISEASE Horning, S. J., Ang, P. T., Hoppe, R. T., & Rosenberg, S. A. (1992). THE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE, ALKERAN AND VINBLASTINE (PAVE) AND RADIOTHERAPY FOR LOCALLY EXTENSIVE AND ADVANCED STAGE HODGKINS-DISEASE. ANNALS OF ONCOLOGY, 3(9), 747-754.
  
• THE MANAGEMENT OF HODGKINS-DISEASE IN RELAPSE AFTER PRIMARY RADIATION-THERAPY Hoppe, R. T. (1992). THE MANAGEMENT OF HODGKINS-DISEASE IN RELAPSE AFTER PRIMARY RADIATION-THERAPY. EUROPEAN JOURNAL OF CANCER, 28A(11), 1920-1922.
  
• COMBINED-MODALITY THERAPY FOR THE TREATMENT OF HODGKINS-DISEASE Hoppe, R. T. (1992). COMBINED-MODALITY THERAPY FOR THE TREATMENT OF HODGKINS-DISEASE. RADIOTHERAPY / CHEMOTHERAPY INTERACTIONS IN CANCER THERAPY, 26, 172-180.
  
• METASTATIC CARCINOMA IN LYMPH-NODES SIMULATING SYNCYTIAL VARIANT OF NODULAR SCLEROSING HODGKINS-DISEASE Bacchi, C. E., Dorfman, R. F., Hoppe, R. T., Chan, J. Kc., & Warnke, R. A. (1991). METASTATIC CARCINOMA IN LYMPH-NODES SIMULATING SYNCYTIAL VARIANT OF NODULAR SCLEROSING HODGKINS-DISEASE. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 96(5), 589-593.
  
• THE MANAGEMENT OF MYCOSIS-FUNGOIDES AT STANFORD - STANDARD AND INNOVATIVE TREATMENT PROGRAMS Hoppe, R. T. (1991). THE MANAGEMENT OF MYCOSIS-FUNGOIDES AT STANFORD - STANDARD AND INNOVATIVE TREATMENT PROGRAMS. LEUKEMIA, 5, 46-48.
  
• TOTAL LYMPHOID IRRADIATION FOR TREATMENT OF INTRACTABLE CARDIAC ALLOGRAFT-REJECTION Hunt, S. A., Strober, S., Hoppe, R. T., & Stinson, E. B. (1991). TOTAL LYMPHOID IRRADIATION FOR TREATMENT OF INTRACTABLE CARDIAC ALLOGRAFT-REJECTION. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 10(2), 211-216.
  
• OBSERVATIONS ON THE EFFECT OF CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN PATIENTS WITH MYCOSIS-FUNGOIDES Knox, S. J., Levy, R., Hodgkinson, S., Bell, R., Brown, S., & Reichert, T. (1991). OBSERVATIONS ON THE EFFECT OF CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN PATIENTS WITH MYCOSIS-FUNGOIDES. BLOOD, 77(1), 20-30.
  
• TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MANAGEMENT OF MYCOSIS-FUNGOIDES Hoppe, R. T. (1991). TOTAL SKIN ELECTRON-BEAM THERAPY IN THE MANAGEMENT OF MYCOSIS-FUNGOIDES. ROLE OF HIGH ENERGY ELECTRONS IN THE TREATMENT OF CANCER, 25, 80-89.
  
• THE STANFORD EXPERIENCE WITH HIGH-DOSE ETOPOSIDE CYTOREDUCTIVE REGIMENS AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - PRELIMINARY DATA Horning, S. J., Chao, N. J., Negrin, R. S., Hoppe, R. T., Kwak, L. W., & Blume, K. G. (1991). THE STANFORD EXPERIENCE WITH HIGH-DOSE ETOPOSIDE CYTOREDUCTIVE REGIMENS AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - PRELIMINARY DATA. ANNALS OF ONCOLOGY, 2, 47-50.
  
• RADIATION-THERAPY IN THE MANAGEMENT OF HODGKINS-DISEASE Hoppe, R. T. (1990). RADIATION-THERAPY IN THE MANAGEMENT OF HODGKINS-DISEASE. SEMINARS IN ONCOLOGY, 17(6), 704-715.
  
• DISCORDANT EXPRESSION OF ANTIGENS BETWEEN INTRAEPIDERMAL AND INTRADERMAL T-CELLS IN MYCOSIS-FUNGOIDES Michie, S. A., Abel, E. A., Hoppe, R. T., Warnke, R. A., & Wood, G. S. (1990). DISCORDANT EXPRESSION OF ANTIGENS BETWEEN INTRAEPIDERMAL AND INTRADERMAL T-CELLS IN MYCOSIS-FUNGOIDES. AMERICAN JOURNAL OF PATHOLOGY, 137(6), 1447-1451.
  
• Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment. Hoppe, R. T., Wood, G. S., & Abel, E. A. (1990). Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment. Current problems in cancer, 14(6), 293-371.
  
• RADIATION-THERAPY IN THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE BEHAR, R. A., & Hoppe, R. T. (1990). RADIATION-THERAPY IN THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE. CANCER, 66(1), 75-79.
  
• PROGNOSTIC FACTORS FOR PATIENTS RELAPSING AFTER RADIOTHERAPY FOR EARLY-STAGE HODGKINS-DISEASE Roach, M., Brophy, N., Cox, R., Varghese, A., & Hoppe, R. T. (1990). PROGNOSTIC FACTORS FOR PATIENTS RELAPSING AFTER RADIOTHERAPY FOR EARLY-STAGE HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 8(4), 623-629.
  
• LEU-8/CD7 ANTIGEN EXPRESSION BY CD3+ T-CELLS - COMPARATIVE-ANALYSIS OF SKIN AND BLOOD IN MYCOSIS-FUNGOIDES SEZARY-SYNDROME RELATIVE TO NORMAL BLOOD VALUES Wood, G. S., Hong, S. R., Sasaki, D. T., Abel, E. A., Hoppe, R. T., & Morhenn, V. B. (1990). LEU-8/CD7 ANTIGEN EXPRESSION BY CD3+ T-CELLS - COMPARATIVE-ANALYSIS OF SKIN AND BLOOD IN MYCOSIS-FUNGOIDES SEZARY-SYNDROME RELATIVE TO NORMAL BLOOD VALUES. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 22(4), 602-607.
  
• Bone marrow transplantation for hematologic malignancies: the Stanford experience. Chao, N. J., Amylon, M. D., Long, G. D., Negrin, R. S., Hoppe, R. T., & Blume, K. G. (1990). Bone marrow transplantation for hematologic malignancies: the Stanford experience. Clinical transplants, 157-163.
  
• CUTANEOUS LYMPHOID HYPERPLASIA - IMMUNOLOGICAL CHARACTERISTICS AND ASSESSMENT OF CRITERIA RECENTLY PROPOSED AS DIAGNOSTIC OF MALIGNANT-LYMPHOMA Medeiros, L. J., Picker, L. J., Abel, E. A., Hu, C. H., Hoppe, R. T., & Wood, G. S. (1989). CUTANEOUS LYMPHOID HYPERPLASIA - IMMUNOLOGICAL CHARACTERISTICS AND ASSESSMENT OF CRITERIA RECENTLY PROPOSED AS DIAGNOSTIC OF MALIGNANT-LYMPHOMA. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 21(5), 929-942.
  
• OUTCOME OF THE ACUTE GLOMERULAR INJURY IN PROLIFERATIVE LUPUS NEPHRITIS Chagnac, A., Kiberd, B. A., Farinas, M. C., Strober, S., Sibley, R. K., & Myers, B. D. (1989). OUTCOME OF THE ACUTE GLOMERULAR INJURY IN PROLIFERATIVE LUPUS NEPHRITIS. JOURNAL OF CLINICAL INVESTIGATION, 84(3), 922-930.
  
• ACQUIRED IMMUNE TOLERANCE TO CADAVERIC RENAL-ALLOGRAFTS - A STUDY OF 3 PATIENTS TREATED WITH TOTAL LYMPHOID IRRADIATION Strober, S., Dhillon, M., Schubert, M., Holm, B., Engleman, E., & Levin, B. (1989). ACQUIRED IMMUNE TOLERANCE TO CADAVERIC RENAL-ALLOGRAFTS - A STUDY OF 3 PATIENTS TREATED WITH TOTAL LYMPHOID IRRADIATION. NEW ENGLAND JOURNAL OF MEDICINE, 321(1), 28-33.
  
• EXPRESSION OF T-CELL RECEPTOR ANTIGENS IN MYCOSIS-FUNGOIDES AND INFLAMMATORY SKIN-LESIONS Michie, S. A., Abel, E. A., Hoppe, R. T., Warnke, R. A., & Wood, G. S. (1989). EXPRESSION OF T-CELL RECEPTOR ANTIGENS IN MYCOSIS-FUNGOIDES AND INFLAMMATORY SKIN-LESIONS. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 93(1), 116-120.
  
• CLONAL REARRANGEMENTS OF IMMUNOGLOBULIN GENES AND PROGRESSION TO B-CELL LYMPHOMA IN CUTANEOUS LYMPHOID HYPERPLASIA Wood, G. S., Ngan, B. Y., Tung, R., HOFFMAN, T. E., Abel, E. A., & Sklar, J. (1989). CLONAL REARRANGEMENTS OF IMMUNOGLOBULIN GENES AND PROGRESSION TO B-CELL LYMPHOMA IN CUTANEOUS LYMPHOID HYPERPLASIA. AMERICAN JOURNAL OF PATHOLOGY, 135(1), 13-19.
  
• CHARACTERIZATION OF SPLENIC STRUCTURE IN HODGKIN DISEASE BY USING NARROW-BAND FILTRATION OF BACKSCATTERED ULTRASOUND Friedman, P. A., Sommer, F. G., Chen, H. S., RACHLIN, D. J., & Hoppe, R. (1989). CHARACTERIZATION OF SPLENIC STRUCTURE IN HODGKIN DISEASE BY USING NARROW-BAND FILTRATION OF BACKSCATTERED ULTRASOUND. AMERICAN JOURNAL OF ROENTGENOLOGY, 152(6), 1197-1203.
  
• THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE Hoppe, R. T. (1989). THE MANAGEMENT OF BULKY MEDIASTINAL HODGKINS-DISEASE. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 3(2), 265-276.
  
• SMALL LYMPHOCYTIC LYMPHOMA Morrison, W. H., Hoppe, R. T., Weiss, L. M., Picozzi, V. J., & Horning, S. J. (1989). SMALL LYMPHOCYTIC LYMPHOMA. JOURNAL OF CLINICAL ONCOLOGY, 7(5), 598-606.
  
• DETECTION OF CLONAL T-CELL RECEPTOR GENE REARRANGEMENTS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH MYCOSIS-FUNGOIDES SEZARY SYNDROME Weiss, L. M., Wood, G. S., Hu, E., Abel, E. A., Hoppe, R. T., & Sklar, J. (1989). DETECTION OF CLONAL T-CELL RECEPTOR GENE REARRANGEMENTS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH MYCOSIS-FUNGOIDES SEZARY SYNDROME. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 92(4), 601-604.
  
• NON-HODGKIN LYMPHOMA - INFLUENCE OF LYMPHOGRAPHY, CT, AND BONE-MARROW BIOPSY ON STAGING AND MANAGEMENT Pond, G. D., Castellino, R. A., Horning, S., & Hoppe, R. T. (1989). NON-HODGKIN LYMPHOMA - INFLUENCE OF LYMPHOGRAPHY, CT, AND BONE-MARROW BIOPSY ON STAGING AND MANAGEMENT. RADIOLOGY, 170(1), 159-164.
  
• EFFECTS OF IRRADIATION ON THE HUMAN IMMUNE-SYSTEM Hoppe, R. T. (1989). EFFECTS OF IRRADIATION ON THE HUMAN IMMUNE-SYSTEM. RADIATION TOLERANCE OF NORMAL TISSUES, 23, 140-149.
  
• Current Stanford clinical trials for Hodgkin's disease. Hoppe, R. T., Horning, S. J., Hancock, S. L., & Rosenberg, S. A. (1989). Current Stanford clinical trials for Hodgkin's disease. Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer, 117, 182-190.
  
• PROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I-II SUPRADIAPHRAGMATIC HODGKINS-DISEASE LEIBENHAUT, M. H., Hoppe, R. T., Efron, B., Halpern, J., Nelsen, T., & Rosenberg, S. A. (1989). PROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I-II SUPRADIAPHRAGMATIC HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 7(1), 81-91.
  
• VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE Horning, S. J., Hoppe, R. T., Hancock, S. L., & Rosenberg, S. A. (1988). VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 6(12), 1822-1831.
  
• BENIGN AND MALIGNANT FORMS OF ERYTHRODERMA - CUTANEOUS IMMUNOPHENOTYPIC CHARACTERISTICS Abel, E. A., LINDAE, M. L., Hoppe, R. T., & Wood, G. S. (1988). BENIGN AND MALIGNANT FORMS OF ERYTHRODERMA - CUTANEOUS IMMUNOPHENOTYPIC CHARACTERISTICS. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 19(6), 1089-1095.
  
• THE CONTEMPORARY MANAGEMENT OF HODGKIN DISEASE Hoppe, R. T. (1988). THE CONTEMPORARY MANAGEMENT OF HODGKIN DISEASE. RADIOLOGY, 169(2), 297-304.
  
• COMBINED MODALITY THERAPY FOR STAGE-I-II LARGE CELL LYMPHOMA Prestidge, B. R., Horning, S. J., & Hoppe, R. T. (1988). COMBINED MODALITY THERAPY FOR STAGE-I-II LARGE CELL LYMPHOMA. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 15(3), 633-639.
  
• INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS Hancock, S. L., Hoppe, R. T., Horning, S. J., & Rosenberg, S. A. (1988). INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS. ANNALS OF INTERNAL MEDICINE, 109(3), 183-189.
  
• TREATMENT OF LUPUS NEPHRITIS WITH TOTAL LYMPHOID IRRADIATION - OBSERVATIONS DURING A 12-79-MONTH FOLLOW-UP Strober, S., Farinas, M. C., Field, E. H., SOLOVERA, J. J., Kiberd, B. A., & Hoppe, R. T. (1988). TREATMENT OF LUPUS NEPHRITIS WITH TOTAL LYMPHOID IRRADIATION - OBSERVATIONS DURING A 12-79-MONTH FOLLOW-UP. ARTHRITIS AND RHEUMATISM, 31(7), 850-858.
  
• CLINICAL AND IMMUNOLOGICAL STUDIES OF CADAVERIC RENAL-TRANSPLANT RECIPIENTS GIVEN TOTAL-LYMPHOID IRRADIATION AND MAINTAINED ON LOW-DOSE PREDNISONE Saper, V., Chow, D., ENGLEMAN, E. D., Hoppe, R. T., Levin, B., & Strober, S. (1988). CLINICAL AND IMMUNOLOGICAL STUDIES OF CADAVERIC RENAL-TRANSPLANT RECIPIENTS GIVEN TOTAL-LYMPHOID IRRADIATION AND MAINTAINED ON LOW-DOSE PREDNISONE. TRANSPLANTATION, 45(3), 540-546.
  
• POIKILODERMATOUS MYCOSIS-FUNGOIDES AND ATROPHIC LARGE-PLAQUE PARA-PSORIASIS EXHIBIT SIMILAR ABNORMALITIES OF T-CELL ANTIGEN EXPRESSION LINDAE, M. L., Abel, E. A., Hoppe, R. T., & Wood, G. S. (1988). POIKILODERMATOUS MYCOSIS-FUNGOIDES AND ATROPHIC LARGE-PLAQUE PARA-PSORIASIS EXHIBIT SIMILAR ABNORMALITIES OF T-CELL ANTIGEN EXPRESSION. ARCHIVES OF DERMATOLOGY, 124(3), 366-372.
  
• NODULAR AND DIFFUSE TYPES OF LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE Regula, D. P., Hoppe, R. T., & Weiss, L. M. (1988). NODULAR AND DIFFUSE TYPES OF LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE. NEW ENGLAND JOURNAL OF MEDICINE, 318(4), 214-219.
  
• T-CELL ANTIGEN DEFICIENCIES AND CLONAL REARRANGEMENTS OF T-CELL RECEPTOR GENES IN PAGETOID RETICULOSIS (WORINGER-KOLOPP DISEASE) Wood, G. S., Weiss, L. M., Hu, C. H., Abel, E. A., Hoppe, R. T., & Sklar, J. (1988). T-CELL ANTIGEN DEFICIENCIES AND CLONAL REARRANGEMENTS OF T-CELL RECEPTOR GENES IN PAGETOID RETICULOSIS (WORINGER-KOLOPP DISEASE). NEW ENGLAND JOURNAL OF MEDICINE, 318(3), 164-167.
  
• DISSECTION OF THE MECHANISMS OF IMMUNE INJURY IN RHEUMATOID-ARTHRITIS, USING TOTAL LYMPHOID IRRADIATION Gaston, J. Sh., Strober, S., SOLOVERA, J. J., GANDOUR, D., Lane, N., & Allison, A. C. (1988). DISSECTION OF THE MECHANISMS OF IMMUNE INJURY IN RHEUMATOID-ARTHRITIS, USING TOTAL LYMPHOID IRRADIATION. ARTHRITIS AND RHEUMATISM, 31(1), 21-30.
  
• SOLITARY PLASMACYTOMA OF BONE - TREATMENT, PROGRESSION, AND SURVIVAL CHAK, L. Y., Cox, R. S., Bostwick, D. G., & Hoppe, R. T. (1987). SOLITARY PLASMACYTOMA OF BONE - TREATMENT, PROGRESSION, AND SURVIVAL. JOURNAL OF CLINICAL ONCOLOGY, 5(11), 1811-1815.
  
• LUPUS NEPHRITIS AFTER TOTAL LYMPHOID IRRADIATION - PERSISTENT IMPROVEMENT AND REDUCTION OF STEROID-THERAPY Strober, S., Farinas, M. C., Field, E. H., SOLOVERA, J. J., Kiberd, B. A., & Hoppe, R. T. (1987). LUPUS NEPHRITIS AFTER TOTAL LYMPHOID IRRADIATION - PERSISTENT IMPROVEMENT AND REDUCTION OF STEROID-THERAPY. ANNALS OF INTERNAL MEDICINE, 107(5), 689-690.
  
• MYCOSIS-FUNGOIDES - MANAGEMENT WITH TOPICAL NITROGEN-MUSTARD Hoppe, R. T., Abel, E. A., DENEAU, D. G., & Price, N. M. (1987). MYCOSIS-FUNGOIDES - MANAGEMENT WITH TOPICAL NITROGEN-MUSTARD. JOURNAL OF CLINICAL ONCOLOGY, 5(11), 1796-1803.
  
• The non-Hodgkin's lymphomas: pathology, staging, treatment. Hoppe, R. T. (1987). The non-Hodgkin's lymphomas: pathology, staging, treatment. Current problems in cancer, 11(6), 363-447.